In their third interview with Asymmetrex President and CEO James L. Sherley, M.D., Ph.D. since 2020, the editors at TechCompanyNews continue to highlight the company’s progress in developing the first technologies for routine, specific quantification of therapeutic tissue stem cells, like blood hematopoietic stem cells.  The latest interview features CEO Sherley’s recent publication of a new chapter envisioning how innovation in stem cell counting technologies by veterinary medicine will speed their adoption for human stem cell medicine.  Read the complete interview to learn about Asymmetrex’s vision for developing the first automated, electronic tissue stem cell counters for applications in stem cell science and stem cell medicine.

See all Member News